Reinitiation of ustekinumab for psoriasis restores initial benefits, studies show ModernMedicine New York — Analyses of data from ii large, prospective, phase iii studies investigating ustekinumab (Stelara, Janssen Biotech) for the treatment of moderate-to-severe speckle psoriasis are consistent in demonstrating the safety and efficacy of ... STELARA? (ustekinumab)is Effective, Well-Tolerated and Improves Quality of ... istockAnalyst.com (press release) each 14 news articles » Link To Article
No comments:
Post a Comment